Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8733698rdf:typepubmed:Citationlld:pubmed
pubmed-article:8733698lifeskim:mentionsumls-concept:C0008059lld:lifeskim
pubmed-article:8733698lifeskim:mentionsumls-concept:C0005961lld:lifeskim
pubmed-article:8733698lifeskim:mentionsumls-concept:C0023516lld:lifeskim
pubmed-article:8733698lifeskim:mentionsumls-concept:C0206161lld:lifeskim
pubmed-article:8733698lifeskim:mentionsumls-concept:C1522577lld:lifeskim
pubmed-article:8733698lifeskim:mentionsumls-concept:C0681842lld:lifeskim
pubmed-article:8733698lifeskim:mentionsumls-concept:C1262018lld:lifeskim
pubmed-article:8733698pubmed:issue5lld:pubmed
pubmed-article:8733698pubmed:dateCreated1996-11-6lld:pubmed
pubmed-article:8733698pubmed:abstractTextAllogeneic BMT using a non-genotypically HLA-identical donor may be curative for children suffering from lethal haematological diseases, who lack a genotypically HLA-identical donor. Unfortunately, graft failures are often seen, especially after T cell depletion of the graft. We studied whether untimely decreased counts of leucocytes and reticulocytes in peripheral blood might predict graft failure at an early stage. Fifty-five recipients of a non-genotypically HLA-identical BM graft were included in the study; data from these children were compared with those of 77 recipients of a genotypically HLA-identical BM graft. Time-related reference values of peripheral blood leucocyte and reticulocyte counts were established in graft recipients with proven donor-origin recovery after BMT. Graft failure after nonHLA-identical BMT was observed in 16 out of 55 children (29%) and after HLA-identical BMT in one out of 77 (1.3%). With respect to early graft failure, the predictive value of granulocyte numbers falling below the lower limit of the reference values and a rapid decline of reticulocyte numbers after their appearance in peripheral blood was 100% (95% confidence intervals of 83-100% and of 80-100%, respectively). Early immunosuppressive intervention was applied in six patients and was successful in three of them.lld:pubmed
pubmed-article:8733698pubmed:languageenglld:pubmed
pubmed-article:8733698pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8733698pubmed:citationSubsetIMlld:pubmed
pubmed-article:8733698pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8733698pubmed:statusMEDLINElld:pubmed
pubmed-article:8733698pubmed:monthMaylld:pubmed
pubmed-article:8733698pubmed:issn0268-3369lld:pubmed
pubmed-article:8733698pubmed:authorpubmed-author:VossenJ MJMlld:pubmed
pubmed-article:8733698pubmed:authorpubmed-author:HaraldssonAAlld:pubmed
pubmed-article:8733698pubmed:authorpubmed-author:Van den...lld:pubmed
pubmed-article:8733698pubmed:authorpubmed-author:Van TolM JMJlld:pubmed
pubmed-article:8733698pubmed:authorpubmed-author:GerritsenE...lld:pubmed
pubmed-article:8733698pubmed:authorpubmed-author:StamE DEDlld:pubmed
pubmed-article:8733698pubmed:issnTypePrintlld:pubmed
pubmed-article:8733698pubmed:volume17lld:pubmed
pubmed-article:8733698pubmed:ownerNLMlld:pubmed
pubmed-article:8733698pubmed:authorsCompleteYlld:pubmed
pubmed-article:8733698pubmed:pagination781-7lld:pubmed
pubmed-article:8733698pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:meshHeadingpubmed-meshheading:8733698-...lld:pubmed
pubmed-article:8733698pubmed:year1996lld:pubmed
pubmed-article:8733698pubmed:articleTitleFollow-up of leucocyte and reticulocyte counts for the prediction of early graft failure after non-HLA-identical BMT in children.lld:pubmed
pubmed-article:8733698pubmed:affiliationDepartment of Paediatrics, Leiden University Hospital, The Netherlands.lld:pubmed
pubmed-article:8733698pubmed:publicationTypeJournal Articlelld:pubmed